Vivo Bio Tech Ltd

Vivo Bio Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vivo Bio Tech Ltd

₹ 27.6 1.77%
29 May - close price
vivobio.com BSE: 511509
About

Incorporated in 1987, Vivo Bio Tech Ltd is a supplier of SPF lab animals and is a breeder
& distributor of rodent models.

Key Points

Business Overview:[1]
VBTL is a full-service preclinical contract research organisation (CRO) and specific pathogen free (SPF) laboratory animal breeder offering drug development and discovery services to pharmaceutical and biotech companies world-wide in accordance with OECD – GLP having applicability in OECD member countries and is accredited by AAALAC International. VBTL offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, etc.

Website BSE
  • Market Cap ₹ 61.2 Cr.
  • Current Price ₹ 27.6
  • High / Low ₹ 43.4 / 20.4
  • Stock P/E 13.5
  • Book Value ₹ 43.8
  • Dividend Yield 0.00 %
  • ROCE 9.04 %
  • ROE 5.68 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.63 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.35% over past five years.
  • Promoter holding is low: 35.4%
  • Company has a low return on equity of 5.30% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.65%
  • Working capital days have increased from 67.4 days to 100 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
13.54 14.76 11.58 9.26 12.85 11.76 10.13 12.04 12.21 12.29 12.51 13.11 13.51
8.62 7.63 7.09 4.40 6.48 6.39 5.77 6.45 6.67 7.27 7.03 7.69 8.02
Operating Profit 4.92 7.13 4.49 4.86 6.37 5.37 4.36 5.59 5.54 5.02 5.48 5.42 5.49
OPM % 36.34% 48.31% 38.77% 52.48% 49.57% 45.66% 43.04% 46.43% 45.37% 40.85% 43.80% 41.34% 40.64%
0.01 0.02 0.00 0.00 0.03 0.01 0.01 4.63 0.01 0.15 0.14 0.13 0.14
Interest 2.08 2.01 1.95 2.09 2.22 1.52 1.92 2.06 1.84 1.68 1.50 1.47 1.40
Depreciation 2.30 2.26 2.29 2.30 2.28 2.43 2.23 2.29 2.25 2.25 2.64 2.57 2.66
Profit before tax 0.55 2.88 0.25 0.47 1.90 1.43 0.22 5.87 1.46 1.24 1.48 1.51 1.57
Tax % 72.73% 28.47% 44.00% 29.79% 31.05% 48.95% 27.27% 10.73% 43.84% 14.52% 9.46% 42.38% 20.38%
0.15 2.06 0.14 0.33 1.32 0.74 0.17 5.23 0.82 1.06 1.34 0.87 1.25
EPS in Rs 0.10 1.38 0.09 0.22 0.89 0.50 0.11 3.51 0.51 0.62 0.67 0.39 0.57
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
16.13 17.79 28.58 34.13 47.00 55.83 55.35 51.78 51.39 52.23 45.45 46.67 51.42
14.38 14.99 24.87 26.51 36.11 46.32 42.88 33.98 35.30 30.39 24.19 26.11 30.01
Operating Profit 1.75 2.80 3.71 7.62 10.89 9.51 12.47 17.80 16.09 21.84 21.26 20.56 21.41
OPM % 10.85% 15.74% 12.98% 22.33% 23.17% 17.03% 22.53% 34.38% 31.31% 41.82% 46.78% 44.05% 41.64%
0.88 0.95 0.89 0.40 0.13 0.01 0.05 0.08 0.10 0.04 0.04 4.80 0.56
Interest 0.39 0.51 0.47 1.29 2.37 2.64 3.10 3.67 4.27 7.99 7.95 7.55 6.05
Depreciation 1.56 3.05 3.35 3.90 4.64 5.06 5.17 5.59 7.45 9.27 9.29 9.02 10.12
Profit before tax 0.68 0.19 0.78 2.83 4.01 1.82 4.25 8.62 4.47 4.62 4.06 8.79 5.80
Tax % 55.88% -142.11% -16.67% 11.66% 21.95% -23.08% -4.47% 34.11% 50.78% 42.64% 37.93% 17.18%
0.29 0.46 0.91 2.50 3.12 2.25 4.44 5.68 2.20 2.65 2.53 7.28 4.52
EPS in Rs 0.31 0.49 0.97 2.67 3.17 1.82 3.45 4.23 1.54 1.78 1.70 4.24 2.25
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 10%
5 Years: -3%
3 Years: -3%
TTM: 11%
Compounded Profit Growth
10 Years: 23%
5 Years: -3%
3 Years: 20%
TTM: -35%
Stock Price CAGR
10 Years: -4%
5 Years: -16%
3 Years: 0%
1 Year: -27%
Return on Equity
10 Years: 9%
5 Years: 7%
3 Years: 5%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 9.35 9.35 9.35 9.35 9.85 12.35 12.89 13.42 14.26 14.90 14.90 17.16 22.10
Reserves -0.83 -0.18 0.71 3.22 9.46 14.92 20.14 29.11 32.87 36.97 39.50 60.74 74.67
6.62 5.69 16.91 27.06 25.12 21.68 24.37 30.96 67.44 62.39 73.06 54.03 56.53
24.90 26.57 18.69 11.49 15.08 6.37 6.29 6.03 7.91 8.77 9.67 11.30 11.88
Total Liabilities 40.04 41.43 45.66 51.12 59.51 55.32 63.69 79.52 122.48 123.03 137.13 143.23 165.18
20.59 19.69 23.54 28.57 27.66 30.01 34.99 52.05 95.17 88.87 80.37 88.24 83.16
CWIP 0.00 0.07 0.04 2.96 3.94 0.07 0.15 0.32 0.87 1.90 9.21 12.84 12.86
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
19.45 21.67 22.08 19.59 27.91 25.24 28.55 27.15 26.44 32.26 47.55 42.15 69.16
Total Assets 40.04 41.43 45.66 51.12 59.51 55.32 63.69 79.52 122.48 123.03 137.13 143.23 165.18

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2.79 2.25 8.81 -5.66 11.11 -0.78 8.61 14.18 16.64 14.83 15.52 11.83
-1.42 -2.04 -7.20 -11.84 -4.72 -3.53 -10.23 -22.82 -51.11 -4.00 -7.95 -15.84
-0.44 -0.89 -0.32 6.83 -3.43 0.72 2.09 8.78 35.02 -11.18 -7.56 3.90
Net Cash Flow 0.93 -0.68 1.30 -10.67 2.96 -3.59 0.47 0.14 0.55 -0.34 0.01 -0.11
Free Cash Flow 1.37 0.21 1.61 -17.50 6.39 -4.31 -1.62 -8.64 -34.47 10.83 7.57 -4.01
CFO/OP 159% 81% 234% -70% 110% -13% 68% 96% 118% 77% 80% 65%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 97.30 88.43 48.79 82.03 91.48 54.98 69.11 51.39 85.37 86.52 94.76 87.98
Inventory Days 42.06 557.61 169.23 204.47 289.48 255.75 451.13 672.29 312.99 429.70 831.44 491.08
Days Payable 1,160.13 814.41 362.93 242.14 304.36 152.08 166.72 70.37 74.02 50.68 100.49 61.78
Cash Conversion Cycle -1,020.76 -168.38 -144.91 44.36 76.61 158.65 353.52 653.31 324.35 465.53 825.71 517.29
Working Capital Days -412.75 -353.72 -131.29 19.25 -13.28 36.22 35.15 28.76 8.10 38.09 63.76 100.26
ROCE % 7.94% 4.67% 5.98% 12.37% 15.18% 9.55% 13.82% 18.78% 9.29% 11.02% 9.94% 9.04%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Workforce
Number of Employees ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Pre-clinical Research Facility Area
Sq. Ft. ・Standalone data
Campus Size
Acres ・Standalone data
Number of Supported Firms/Clients
Count ・Standalone data
Annual Animal Production Capacity
Numbers ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
42.08% 42.08% 42.08% 42.08% 42.08% 42.08% 38.89% 40.85% 39.07% 35.17% 35.17% 35.43%
57.92% 57.91% 57.92% 57.92% 57.92% 57.91% 61.12% 59.16% 60.94% 64.84% 64.84% 64.58%
No. of Shareholders 12,98913,00615,61518,97118,85219,54521,16721,93521,86521,64721,62221,427

Documents

Announcements

Annual reports

Credit ratings